Developing Robust Potency Assays for Validation

Dr. Peter Wunderli

In this episode, Dr. Wunderli discusses PPD's recent laboratory facility expansion, outlines challenges and critical factors in cell-based bio bioassay product development, talks about disease states suitable for this type of technology, and finally, takes a look into the future of cell-based assays.

Thought Leader:
Peter Wunderli, Ph.D., Associate Director, Biopharmaceutical Services at PPD

Download Podcast

Download Podcast Transcript

Download Related White Paper

See All PharmaVOICE Podcasts

See All PharmaVOICE White Papers